CXF-009
CXF-009 is a selective and covalent FGFR4 inhibitor, with the IC50 of 48 nM. CXF-009 targeting Cys477 and Cys552 of FGFR4, and can be used for the study of hepatocellular carcinoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2727084-00-4
- 分子式: C33H38N8O5
- 分子量:626.71
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
|
FGFR4 48 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BaF3 | IC50 |
>5000 nM
Compound: CXF-009
|
Antiproliferative activity against mouse BaF3 cells incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| BaF3 | IC50 |
1562 nM
Compound: CXF-009
|
Antiproliferative activity against mouse BaF3 cells expressing FGFR1 incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells expressing FGFR1 incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| BaF3 | IC50 |
1971 nM
Compound: CXF-009
|
Antiproliferative activity against mouse BaF3 cells expressing FGFR2 incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells expressing FGFR2 incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| BaF3 | IC50 |
38 nM
Compound: CXF-009
|
Antiproliferative activity against mouse BaF3 cells expressing FGFR4 incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells expressing FGFR4 incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| BaF3 | IC50 |
777 nM
Compound: CXF-009
|
Antiproliferative activity against mouse BaF3 cells expressing FGFR3 incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells expressing FGFR3 incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| HCC1937 | IC50 |
>10 μM
Compound: CXF-009
|
Antiproliferative activity against human HCC1937 cells after 72 hrs by CCK8 assay
Antiproliferative activity against human HCC1937 cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
| Hep 3B2 | IC50 |
0.9 μM
Compound: CXF-009
|
Antiproliferative activity against human Hep3B cells after 72 hrs by CCK8 assay
Antiproliferative activity against human Hep3B cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
| Huh-7 | IC50 |
0.73 μM
Compound: CXF-009
|
Antiproliferative activity against human Huh-7 cells after 72 hrs by CCK8 assay
Antiproliferative activity against human Huh-7 cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
| MDA-MB-453 | IC50 |
0.73 μM
Compound: CXF-009
|
Antiproliferative activity against human MDA-MB-453 cells after 72 hrs by CCK8 assay
Antiproliferative activity against human MDA-MB-453 cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
化学情報
-
CAS 番号 2727084-00-4
-
分子量 626.71
-
分子式 C33H38N8O5
-
SMILES
O=C(NC1=C(NC2=NC=C3C(N(CCCN4CCN(CC4)C(C=C)=O)C(N(C3)C5=CC(OC)=CC(OC)=C5)=O)=N2)C=CC=C1)C=C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)